Clinigen Group plc Grant of share options (7128V)
November 07 2017 - 5:00AM
UK Regulatory
TIDMCLIN
RNS Number : 7128V
Clinigen Group plc
07 November 2017
7 November 2017
Grant of Share Options
Clinigen Group plc (AIM: CLIN, "Clinigen" or the "Company"),
announces that, on 6 November 2017, the following Directors were
granted share options over a total of 122,995 ordinary shares of
0.1 pence each ("Ordinary Shares"), granted under the Clinigen
Group Long Term Incentive Plan 2015. The options are nil cost
options intended to vest on 16 October 2020 subject to the
achievement of certain performance criteria.
The additional share options granted to Shaun Chilton are in
relation to the completion of the acquisition of Quantum Pharma
plc.
Director/PDMR Number Total number Total number Total number
of share of share of ordinary of ordinary
options options shares shares
granted now held now held (excluding
share options)
as % issued
share capital
--------------- ---------- ------------- ------------- ----------------
Shaun Chilton 43,630 318,420 312,943 0.26%
--------------- ---------- ------------- ------------- ----------------
Chris Rigg 79,365 79,365 6,563 0.01%
--------------- ---------- ------------- ------------- ----------------
-Ends-
Contact details
Clinigen Group plc Tel: +44 (0) 1283
495010
Shaun Chilton, Group Chief
Executive Officer
Martin Abell, Group Chief
Financial Officer
Numis Securities Limited Tel: +44 (0) 20
7260 1000
Michael Meade / Freddie Barnfield
(Nominated Adviser)
James Black / Tom Ballard
(Corporate Broking)
RBC Capital Markets - Joint Tel: +44 (0) 20
Broker 7653 4000
Marcus Jackson / Elliot Thomas
/ Jack Wood
Instinctif Partners Tel: +44 (0) 20
7457 2020
Melanie Toyne-Sewell / Alex
Shaw / Deborah Bell Email: clinigen@instinctif.com
About Clinigen Group
Clinigen Group plc (AIM: CLIN) is a global pharmaceutical and
services company with a unique combination of businesses focused on
providing access to medicines. Its mission is to deliver the right
medicine to the right patient at the right time through three areas
of global medicine supply; clinical trial, unlicensed and licensed
medicines.
For more information, please visit www.clinigengroup.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHBFBRTMBBMBIR
(END) Dow Jones Newswires
November 07, 2017 05:00 ET (10:00 GMT)
Clinigen (LSE:CLIN)
Historical Stock Chart
From Apr 2024 to May 2024
Clinigen (LSE:CLIN)
Historical Stock Chart
From May 2023 to May 2024